INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
INTELLIGENT BIO SOLUTIONS INC.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026
$1.53+0.03 (+2.00%)
Close on Oct 19, 2026
- Market cap
- $3.83M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.77 (−85.15%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
INTELLIGENT BIO SOLUTIONS INC. grew revenue 38.1% to $4.22M over the twelve months to Jun 30, 2026. Free cash flow was -$12.05M.
Revenue
$4.22M
+38.1% vs. a year earlier
Operating income
-$12.61M
TTM Q4 2026
Free cash flow
-$12.05M
TTM Q4 2026
EPS, diluted
-$8.44
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.83M
- P/E ratio
- –
- Price to sales
- 0.91
- Price to book
- 0.69
- Dividend yield
- –
- Free cash flow yield
- -314.98%
Fundamentals
- Revenue
- $4.22M
- Net income
- -$12.43M
- EPS, diluted
- -$8.44
- Free cash flow
- -$12.05M
- Book value per share
- $2.20
- Diluted shares
- 3M
Eight years at a glance
Fiscal years 2019 to 2026, USD
Revenue
$4.22M+38.1% YoY
Gross profit
$2.05M+64.4% YoY
Operating income
-$12.61M
Net income
-$12.43M
EPS, diluted
-$8.44
Free cash flow
-$12.05M
Reported period